Pharmacy

Novo Nordisk's new-generation basal insulin Tresiba approved in China

The FINANCIAL -- Novo Nordisk on September 27 announced that the China Food and Drug Administration (CFDA) has approved Tresiba (insulin degludec) for the treatment of diabetes in China. Tresiba is a new-generation, once-daily basal insulin with an ultra-long duration of action which allows for flexibility in day-to-day ...

The world is running out of antibiotics, WHO report confirms

The FINANCIAL -- A report, Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched on September 20 by WHO ...

Novartis drug Rydapt receives EU approval for newly diagnosed FLT3-mutated AML and three types of advanced SM

The FINANCIAL -- Novartis on September 20 announced that the European Commission (EC) approved Rydapt (midostaurin) for two indications in rare, hard-to-treat ...

Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on September 18 announced it has entered into two agreements to sell the remaining assets of its specialty global women’s health business for ...

Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT

The FINANCIAL -- Pfizer Inc. on September 19 announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted 6 in favor and 6 against the benefit-risk ...

GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus

The FINANCIAL -- GSK announced on September 27 that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic ...

China Food and Drug Administration Approves Gilead’s Sovaldi

The FINANCIAL -- Gilead Sciences, Inc. announced on September 25 that the China Food and Drug Administration (CFDA) has approved Sovaldi (sofosbuvir 400mg), a once-daily oral nucleotide analog ...

Roche receives European approval for Actemra /RoActemra in giant cell arteritis

The FINANCIAL -- Roche announced on September 22 that the European Commission (EC) has approved Actemra/RoActemra (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and ...

Roche receives EU approval for Gazyvaro

The FINANCIAL -- Roche announced on September 22 that the European Commission has approved Gazyvaro (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people ...

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

The FINANCIAL -- Merck KGaA, Darmstadt, Germany, and Pfizer Inc. on September 21 announced that the European Commission (EC) has granted marketing authorization for BAVENCIO (avelumab) as a ...